Beth Shaz, MD, MBA, has been accepted as a fellow in the 2023-2024 Executive Leadership in Health Care (ELH) Program, a track of the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program.
Shaz joined the Pathology Department in 2020 as a professor and serves as the deputy director of the Marcus Center for Cellular Cures. In addition, she is co-director of the Stem Cell Laboratory; a member of the Duke Cancer Institute and Margolis Center for Health Policy; past president of Association for the Advancement of Blood & Biotherapies (AABB) Board of Directors; a scientific member of Biomedical Excellence for Safer Transfusion (BEST Collaborative); and an associate editor of “Transfusion.”
Established in 1995, the ELAM program offers a rigorous one-year fellowship of leadership training with extensive coaching, networking and mentoring opportunities aimed at growing the national pool of qualified women candidates for leadership in academic medicine, dentistry, public health and pharmacy. The program’s goal is to foster higher levels of women in executive leadership roles. In 2022 ELAM launched ELH as a partner program to focus on the unique needs of aspiring executive leaders in health care.
Women faculty who have held the rank of associate professor or higher for at least two years are eligible to apply. Selection is based on evidence of their leadership potential.